iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Mankind Pharma Secures ₹5,000 Crore NCDs by Pledging 56.31% Stake in BSV

8 Jan 2025 , 04:01 PM

Mankind Pharma has granted 56.31% of its equity shares in Bharat Serums and Vaccines Ltd (BSV), a wholly owned subsidiary, to Catalyst Trusteeship Ltd.
This forms one of the conditions for securing its listed NCDs worth ₹5,000 crore.

The Deed of Trust has been executed on October 10, 2024 between the group company Mankind Pharma and Catalyst Trusteeship. The NCDs issued are categorized, rated, secured, redeemable, and transferable, distributed across three series. Catalyst Trusteeship Ltd is the Common Security Trustee, so there is always security for the holders of NCDs.

For the further strengthening of the security that covers the NCDs, Mankind Pharma uses the residual equity in BSV. Bharat Serums and Vaccines Ltd is one of the prominent companies in the biopharma industry and deals with critical care, women’s health, and vaccines. It will be seen that Mankind Pharma is using the stake in BSV to achieve the long-term growth of the company while ensuring the financial liabilities.

This will comfort the investors with the fact that the company takes proactive measures for transparency and trust in its dealings. Mankind Pharma promises it can fulfill promises, and this goes hand in hand with its commitment to the health care sector as BSV adds innovative contributions to the sector.

Related Tags

  • Mankind Pharma
  • Mankind Pharma News
  • Pharma news
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.